Ruditapes decussatus anticancer peptides
downstream-application
Ruditapes decussatus anticancer peptides: downstream-application. De novo sequencing of 135 peptides purified from the edible clam Ruditapes decussatus, 57 of them predicted to have anticancer activity, with fractions cytotoxic to…
De novo sequencing of 135 peptides purified from the edible clam Ruditapes decussatus, 57 of them predicted to have anticancer activity, with fractions cytotoxic to liver and colorectal cancer cell lines.
| Kind | downstream-application |
| Deep learning | no |
| Acquisition | DDA |
| Application area | Bioactive peptides |
Data
What the papers describing this method trained it on and reported its results on, as each paper states it. A version is named only where the paper names one.
Deposited
Paper describing it
- Novel peptides from the edible bivalve Ruditapes decussatus target apoptosis, autophagy, and FGF19-FGFR4 signaling in human cancer cell lines (2025, Scientific Reports, peer-reviewed)